Nitin Barman, MD
Interventional Cardiology · New York, NYNPI 1730299314
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (42.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 75.6% of it on its own, with 34 other manufacturers making up the rest. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 297 payments — averaging $471.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$106K
- Terumo Medical Corporation$16K
- Cardiovascular Systems Inc.$9K
- Abbott$2K
- ZOLL Circulation Inc$1K
- Atrium Medical Corporation$900
- plus $5K from 29 others
Across 127 payments — averaging $2581.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$277K
- Novartis$42K
- Heartflow, Inc.$4K
- Angiodynamics, Inc.$3K
- Abbott$2K
What the payments were for
- Consulting fees$18,56513%
- Speaking & faculty fees$51,71337%
- Grants$60,00043%
- Travel & lodging$8141%
- Food & beverage$8,6526%
- Education$1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 83 | $105,826 |
| Terumo Medical Corporation | 27 | $16,135 |
| Cardiovascular Systems Inc. | 21 | $8,967 |
| Abbott | 39 | $1,747 |
| ZOLL Circulation Inc | 2 | $1,439 |
| Atrium Medical Corporation | 1 | $900 |
| Maquet Cardiopulmonary GmbH | 1 | $650 |
| Medtronic | 6 | $540 |
| Shockwave Medical, Inc | 8 | $509 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $350 |
| Abiomed | 6 | $323 |
| BD | 1 | $305 |
| Novartis | 15 | $261 |
| Amgen | 12 | $244 |
| Johnson & Johnson | 8 | $189 |
| Biotronik Inc. | 1 | $176 |
| Pfizer | 7 | $172 |
| AstraZeneca | 7 | $138 |
| Cagent Vascular Inc | 2 | $134 |
| Merck | 6 | $133 |
| Boehringer Ingelheim | 4 | $109 |
| Chiesi USA, Inc. | 2 | $88 |
| Bard Peripheral Vascular, Inc. | 2 | $75 |
| Acist Medical Systems, Inc. | 2 | $74 |
| Alnylam Pharmaceuticals Inc. | 2 | $62 |
| Bayer | 2 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| Endologix LLC | 1 | $49 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $42 |
| Lexicon Pharmaceuticals, Inc. | 2 | $41 |
| Philips North America LLC | 1 | $31 |
| Cordis US CORP. | 1 | $26 |
| Heartflow, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ATHERECTOMY$40,125
- GENERAL VASCULAR ACCESS$13,875
- Coronary Orbital Atherectomy System$8,584
- Heartrail$6,125
- TR Band$6,125
- ROTABLATOR$6,000
- GlideWire$5,830
- ROTAWIRE$5,438
- GENERAL CATHETER$5,000
- Optitorque$4,200
- Glidesheath$4,200
- ROTAPRO$3,319
- Watchman$3,000
- METACROSS OTW$1,925
- GLIDESHEATH SLENDER$1,925
- TherOx DS2 Console$1,439
- Catheter$1,439
- Downstream Cartridge$1,439
- HLS Set$650
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$285
How this compares
$139,920 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Jaikirshan KhatriNew York$307K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.